The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies
Open accessAbstract
Amorphous solid dispersions (ASDs) are popular for enhancing the solubility and bioavailability of poorly water-soluble drugs. Various approaches have been employed to produce ASDs and novel techniques are emerging. This review provides an updated overview of manufacturing techniques for preparing ASDs. As physical stability is a critical quality attribute for ASD, the impact of formulation, equipment, and process variables, together with the downstream processing on physical stability of ASDs have been discussed. Selection strategies are proposed to identify suitable manufacturing methods, which may aid in the development of ASDs with satisfactory physical stability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–218 of 218
Paidi, S. K., Jena, S. K., Ahuja, B. K., Devasari, N., & Suresh, S. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12358 · Cited by 39
Kim, M., Ha, E., Kim, J.-S., Baek, I., Yoo, J., Jung, Y., & Moon, H. R. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s90706 · Cited by 37
Chen, Y., Ho, H., Chiou, J.-D., & Sheu, M. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.043 · Cited by 37
Tabbakhian, M., Hasanzadeh, F., Tavakoli, N., & Jamshidian, Z. (2014) · Europe PMC (PubMed Central) · Cited by 36
Mohammadi, G., Hemati, V., Nikbakht, M. R., et al. (2014) · Powder Technology · doi:10.1016/j.powtec.2014.03.014 · Cited by 33
Worku, Z. A., Aarts, J., Singh, A. K., & den Mooter, G. V. (2014) · Molecular Pharmaceutics · doi:10.1021/mp4003943 · Cited by 31
PEG/PLA core/shell particles from coaxial electrohydrodynamic spray drying
Ho, H., & Lee, J. (2011) · Macromolecular Research · doi:10.1007/s13233-011-0814-z · Cited by 25
Hu, J., Johnston, K. P., & Williams, R. O. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120039212 · Cited by 22
GRAM TO KILOGRAM SCALE-UP OF SUPERCRITICAL ANTI-SOLVENT PROCESS
Jung, J., Clavier, J.-Y., & Perrut, M. (2003) · Cited by 18
Beck‐Broichsitter, M., Bohr, A., Santiago, L. A., Klingl, A., & Kissel, T. (2016) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2015.1098661 · Cited by 17
Amorphization of crystalline active pharmaceutical ingredients via formulation technologies
Lim, R. T. Y., Ong, C. K., Cheng, S., & Ng, W. K. (2017) · Powder Technology · doi:10.1016/j.powtec.2017.01.004 · Cited by 14
Theismann, E., Keppler, J. K., Owen, M. R., Schwarz, K., & Schlindwein, W. S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11040154 · Cited by 14
Pharmaceutical Cryogenic Technologies
Yang, W. P., Owens, D. E., & Williams, R. O. (2011) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-1144-4_11 · Cited by 12
Dobry, D. E., Settell, D. M., & Baumann, J. M. (2015) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse530 · Cited by 10
Trends in Colloid and Interface Science VIII
Ottewill, R., & Rennie, A. (1994) · Steinkopff eBooks · doi:10.1007/bfb0115123 · Cited by 9
Giri, T. K., Jana, P., & Sa, B. (2008) · Journal of Scientific & Industrial Research · Cited by 9
Narayan, P. J., Porter, W. W., Brackhagen, M., & Tucker, C. J. (2015) · Wiley eBooks · doi:10.1002/9780470571224.pse523 · Cited by 6
Emerging Technologies to Increase the Bioavailability of Poorly Water-Soluble Drugs
Hughey, J. R., & McGinity, J. W. (2011) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-1144-4_13 · Cited by 5
Cited by
Meola, T. R., Kamath, S., Elz, A. S., Prestidge, C. A., Wignall, A., & Joyce, P. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114453 · Cited by 10
Metadata
- Authors
- Bhujbal, S. V., Mitra, B., Jain, U., Gong, Y., Agrawal, A., Karki, S., Taylor, L. S., Kumar, S., & (Tony) Zhou, Q.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 11
- Issue
- 8
- Pages
- 2505-2536
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3169596185
- Cited by
- 556
- References
- 218
- FWCI
- 25.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.